J&J COVID-19 vaccine under EU review over blood clots
Europe’s drug regulator said on Friday that it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson’s COVID-19 vaccine.
Read More
Hopefully Bringing Real News
Canada’s ex-finance minister breached ethics rules in charity dealings 
Judge axes employee wage claims, keeps others in Wawa data breach case